Verona Pharma plc - American Depositary Shares (VRNA) SEC filings
VRNA SEC filings moved a median of +0.07% by the close. VRNA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VRNA overview →
45 measured VRNA SEC filing events.
Where these VRNA SEC filings landedvs 40 measured VRNA SEC filing reactions
| Middle 50% of VRNA SEC filing reactions | -0.62% to +4.12% |
|---|---|
| Median reaction (to close) | +0.07% |
| Measured reactions | 40 |
Point-in-time · zero look-ahead
Half of the 40 VRNA SEC filing events with a measured close landed between -0.62% and +4.12%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Verona Pharma plc | SEC filing · Form 15-12G | — | — | |
| Form 8-K Verona Pharma plc For: Oct 07 | SEC filing · Form 8-K | — | — | |
| Form POS AM Verona Pharma plc | SEC filing · Form POS | — | — | |
| Form POSASR Verona Pharma plc | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Verona Pharma plc | SEC filing · Form S-8 | — | — | |
| Form 8-K Verona Pharma plc For: Sep 24 | SEC filing · Form 8-K | -0.05% | -0.06% | |
| Form DEFA14A Verona Pharma plc | SEC filing · Form DEFA14A | -0.02% | +0.07% | |
| Form 8-K Verona Pharma plc For: Sep 05 | SEC filing · Form 8-K | -0.13% | -0.05% | |
| Form DEFA14A Verona Pharma plc | SEC filing · Form DEFA14A | -0.13% | -0.05% | |
| Form DEFM14A Verona Pharma plc | SEC filing · Form DEFM14A | +0.14% | +0.47% | |
| Form 10-Q Verona Pharma plc For: Jun 30 | SEC filing · Form 10-Q | -0.04% | +0.07% | |
| Form PREM14A Verona Pharma plc For: Aug 05 | SEC filing · Form PREM14A | -0.04% | -0.03% | |
| Form DEFA14A Verona Pharma plc | SEC filing · Form DEFA14A | +0.07% | -0.06% | |
| Form DEFA14A Verona Pharma plc | SEC filing · Form DEFA14A | +0.02% | -0.02% | |
| Form 8-K Verona Pharma plc For: Jul 08 | SEC filing · Form 8-K | +0.01% | -0.08% | |
| Form DEFA14A Verona Pharma plc | SEC filing · Form DEFA14A | +0.01% | -0.08% | |
| Form 10-Q Verona Pharma plc For: Mar 31 | SEC filing · Form 10-Q | -5.10% | -1.30% | |
| Form 8-K Verona Pharma plc For: Apr 29 | SEC filing · Form 8-K | -5.10% | -1.30% | |
| Form 8-K Verona Pharma plc For: Apr 24 | SEC filing · Form 8-K | +1.91% | +4.13% | |
| Form 8-K Verona Pharma plc For: Mar 25 | SEC filing · Form 8-K | -0.25% | -2.37% | |
| Form ARS Verona Pharma plc For: Dec 31 | SEC filing · Form ARS | +0.75% | +4.91% | |
| Form DEF 14A Verona Pharma plc For: Apr 24 | SEC filing · Form DEF | +0.75% | +4.91% | |
| Form 10-K Verona Pharma plc For: Dec 31 | SEC filing · Form 10-K | +1.04% | +0.18% | |
| Form 8-K Verona Pharma plc For: Feb 27 | SEC filing · Form 8-K | +1.04% | +0.18% | |
| Form S-8 Verona Pharma plc | SEC filing · Form S-8 | +1.72% | +4.63% | |
| Form 8-K Verona Pharma plc For: Jan 07 | SEC filing · Form 8-K | -2.84% | +6.95% | |
| Form 10-Q Verona Pharma plc For: Sep 30 | SEC filing · Form 10-Q | -1.54% | +15.61% | |
| Form 8-K Verona Pharma plc For: Nov 04 | SEC filing · Form 8-K | -1.54% | +15.61% | |
| Form 10-Q Verona Pharma plc For: Jun 30 | SEC filing · Form 10-Q | +0.45% | +7.52% | |
| Form 8-K Verona Pharma plc For: Aug 08 | SEC filing · Form 8-K | +0.45% | +7.52% | |
| Form 8-K Verona Pharma plc For: Jun 26 | SEC filing · Form 8-K | +5.92% | +4.32% | |
| Form 10-Q Verona Pharma plc For: Mar 31 | SEC filing · Form 10-Q | +1.77% | +1.02% | |
| Form S-8 Verona Pharma plc | SEC filing · Form S-8 | +1.77% | +1.02% | |
| Form 8-K Verona Pharma plc For: May 09 | SEC filing · Form 8-K | -1.70% | -3.34% | |
| Form 8-K Verona Pharma plc For: Apr 26 | SEC filing · Form 8-K | +0.32% | -1.49% | |
| Form ARS Verona Pharma plc For: Dec 31 | SEC filing · Form ARS | +1.18% | +4.12% | |
| Form DEF 14A Verona Pharma plc For: Apr 26 | SEC filing · Form DEF | +1.18% | +4.12% | |
| Form PRE 14A Verona Pharma plc For: Apr 26 | SEC filing · Form PRE | +0.62% | -1.18% | |
| Form 10-K Verona Pharma plc For: Dec 31 | SEC filing · Form 10-K | -4.01% | -5.38% | |
| Form 8-K Verona Pharma plc For: Feb 29 | SEC filing · Form 8-K | -4.01% | -5.38% | |
| Form 8-K Verona Pharma plc For: Jan 31 | SEC filing · Form 8-K | -2.01% | -0.43% | |
| Form 8-K Verona Pharma plc For: Dec 27 | SEC filing · Form 8-K | -0.42% | -2.03% | |
| Form 8-K Verona Pharma plc For: Dec 14 | SEC filing · Form 8-K | +1.18% | -1.91% | |
| Form 10-Q Verona Pharma plc For: Sep 30 | SEC filing · Form 10-Q | +0.65% | +0.33% | |
| Form 8-K Verona Pharma plc For: Nov 02 | SEC filing · Form 8-K | +0.83% | +3.03% |
Keep exploring
More VRNA: earnings → · analyst actions → · VRNA overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Novartis AG (NVS) | 326 | +0.03% | 51% |
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.